Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists

Travel Medicine and Infectious Disease

Volumn 11, Issue 6, 2013, Pages 412-420

  Neumayr, Andreas L C ^a,b   Morizot, Gloria ^c   Visser, Leo G ^d   Lockwood, Diana N J ^e   Beck, Bernhard R ^f   Schneider, Stefan ^g   Bellaud, Guillaume ^h   Cordoliani, Florence ⁱ   Foulet, Françoise ^j   Laffitte, Emmanuel A ^k   Buffet, Pierre ^c,l   Blum, Johannes A ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c INSTITUT PASTEUR   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f Tropen und Reisemedizin am Bellevue   (Switzerland)

^g Reha Rheinfelden ^*  (Switzerland)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j Hôpitaux Universitaires Henri Mondor   (France)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Cutaneous leishmaniasis; Immunosuppression; Rheumatology; TNF alpha antagonists; Treatment

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; CERTOLIZUMAB PEGOL; EFALIZUMAB; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; LEFLUNOMIDE; MEGLUMINE ANTIMONATE; METHOTREXATE; MILTEFOSINE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; STIBOGLUCONATE SODIUM; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; EXCISION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SKIN LEISHMANIASIS; TRAVEL; TREATMENT DURATION; TREATMENT OUTCOME;

CUTANEOUS LEISHMANIASIS; IMMUNOSUPPRESSION; RHEUMATOLOGY; TNF-ALPHA ANTAGONISTS; TREATMENT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIPROTOZOAL AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84889660371     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.05.003     Document Type: Article

References (27)

1. J. Marfurt, I. Niederwieser, D. Makia, H.P. Beck, and I. Felger Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP Diagn Microbiol Infect Dis 46 2003 115 124
2. J. Marfurt, A. Nasereddin, I. Niederwieser, C.L. Jaffe, H.P. Beck, and I. Felger Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis J Clin Microbiol 417 2003 3147 3153
3. L. El Hajj, M. Thellier, J. Carriere, F. Bricaire, M. Danis, and E. Caumes Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases Int J Dermatol 43 2004 120 125
4. S. Antinori, A. Cascio, C. Parravicini, R. Bianchi, and M. Corbellino Leishmaniasis among organ transplant recipients Lancet Infect Dis 8 2008 191 199
5. A. Schubach, F. Haddad, M.P. Oliveira-Neto, W. Degrave, C. Pirmez, and G. Grimaldi Jr. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients J Infect Dis 178 1998 911 914
6. C.P. de Oliveira, J. Junger, Mattos M. do Espirito Santo Silva Pires, M.P. Oliveira-Neto, and O. Fernandes Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis Trans R Soc Trop Med Hyg 100 2006 1112 1117
7. G. Harms, G. Schönian, and H. Feldmeier Leishmaniasis in Germany Emerg Infect Dis 9 2003 872 875
8. R.G. Chaudhary, F.E. Bilimoria, and S.K. Katare Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV) Indian J Dermatol Venereol Leprol 74 2008 641 643
9. P.Y. Venencie, P. Bourée, C. Hiesse, A. Vieillefond, O. Lantz, and S. Doukan Disseminated cutaneous leishmaniasis in a case of an immunodepressed woman Ann Dermatol Venereol 120 1993 461 463
10. G. Harms, H. Scherbaum, I. Reiter-Owona, A. Stich, and J. Richter Treatment of imported New World cutaneous leishmaniasis in Germany Int J Dermatology 50 2011 1336 1342
11. J.A. Blum, D.N.J. Lockwood, L. Visser, G. Harms, M.S. Baileye, and E. Caumes Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis International Health 4 2012 153 163
12. J.A. Blum, and C.F. Hatz Treatment of cutaneous leishmaniasis in travelers J Travel Med 16 2009 123 131
13. P.A. Buffet, E. Rosenthal, J.P. Gangneux, E. Lightburne, P. Couppié, and G. Morizot Therapy of leishmaniasis in France: consensus on proposed guidelines Presse Med 40 2011 173 184
14. P. Zanger, I. Kötter, P.G. Kremsner, and S. Gabrysch Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe Clin Microbiol Infect 18 2012 670 676
15. C. Moureau, L. Pothen, D. Wilmes, J.C. Yombi, E. Coche, and P. Hainaut Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist Am J Med 125 2012 e9 e10
16. M.P. Posada-Vergara, J.A. Lindoso, J.E. Tolezano, V.L. Pereira-Chioccola, M.V. Silva, and H. Goto Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS J Infect Dis 192 2005 1819 1822
17. A. Chrusciak-Talhari, R. Ribeiro-Rodrigues, C. Talhari, R.M. Silva Jr., L.C. Ferreira, and S.F. Botileiro Tegumentary leishmaniasis as the cause of immune reconstitution inflammatory syndrome in a patient co-infected with human immunodeficiency virus and Leishmania guyanensis Am J Trop Med Hyg 81 2009 559 564
18. T.A. Patel, and D.N. Lockwood Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases Trop Med Int Health 14 2009 1064 1067
19. I. Molina, V. Falc, M. Crespo, C. Riera, E. Ribera, and A. Curran Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients J Antimicrob Chemother 60 2007 837 842
20. M.C. Mueller, E. Fleischmann, M. Grunke, S. Schewe, J.R. Bogner, and T. Löscher Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab Am J Trop Med Hyg 81 2009 52 54
21. G. Franklin, J. Greenspan, and S. Chen Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis Ann Clin Lab Sci 39 2009 192 195
22. S. Hakimi, S. Rivière, P. Del Giudice, J. Dereure, and A. Le Quellec Localized cutaneous leishmaniasis due to leishmania infantum in a patient treated with infliximab Dermatology 220 2010 63 65
23. S. Baltà-Cruz, M. Alsina-Glbert, A. Mozos-Rocafort, C. Cervera, L. Colomo-Saperas, and A. Del Río Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis Acta Derm Venereol 89 2009 432 433
24. P. Zanger, I. Kötter, A. Raible, T. Gelanew, G. Schönian, and P.G. Kremsner Case report: successful tratment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomale amphotericin B in an immunocompromised traveler returning from Eritrea Am J Trop Med Hyg 84 2011 692 694
25. I.D. Xynos, M.G. Tektonidou, D. Pikazis, and N.V. Sipsas Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe Emerg Infect Dis 15 2009 956 959
26. P. Schneider, J.D. Bouaziz, F. Foulet, T.A. Duong, L.V. Allanore, and M. Bagot Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy Ann Dermatol Venereol 136 2009 815 816
27. K.W. Gomes, A.N. Benevides, F.J. Vieira, M.P. Burlamaqui, A. Vieira Mde, and L.M. Fontenelle Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab Rev Bras Reumatol 52 2012 447 452